Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Clinical Psychopharmacology|August 4, 2026
Olanzapine/Samidorphan-Associated Opioid Withdrawal Reported to US Poison CentersJames B Leonard, Sheila Mohebbi
American Journal of Pharmaceutical Education|August 13, 2021
Student Perspectives on Dismantling Racial Bias in Pharmacy School EducationSarah Temi Sofeso, Sheila Mohebbi, Laura Rambaran, et al.
Journal of the American Pharmacists Association : Japha|August 25, 2021
An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay Area pharmaciesRob Bellman, Sheila Mohebbi, Nikki Nobahar, et al.
Clinical Toxicology (Philadelphia, Pa.)|January 3, 2019
The others: characterizing "other" therapeutic errors reported to a poison centerJames B Leonard, Wendy Klein-Schwartz
The American Journal of Drug and Alcohol Abuse|April 12, 2019
Characterization of intentional-abuse venlafaxine exposures reported to poison control centers in the United StatesJames B Leonard, Wendy Klein-Schwartz
Journal of Psychopharmacology (Oxford, England)|September 6, 2018
Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016James B Leonard, Bruce Anderson, Wendy Klein-Schwartz
Clinical Toxicology (Philadelphia, Pa.)|February 10, 2023
A descriptive study of aripiprazole, brexpiprazole, and cariprazine exposures in children ages 0 to 5 years reported to United States poison centersNicholas Husak, Thomas W Laudone, James B Leonard
Clinical Toxicology (Philadelphia, Pa.)|March 12, 2026
Enhancing U.S. poison center surveillance with verbatim substance uploadJames B Leonard, Kaitlyn Brown, Jonathan M Colvin
Pharmacoepidemiology and Drug Safety|September 23, 2020
Impact of a drug safety communication on the severity of benzonatate exposures reported to poison centersJames B Leonard, Hyunuk Seung, Wendy Klein-Schwartz
Pageof 3